ENTRY       D10353                      Drug
NAME        Demcizumab (USAN/INN)
FORMULA     C6444H10004N1700O2028S52
EXACT_MASS  145315.742
MOL_WEIGHT  145405.9358
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKI SCKASGYSFT AYYIHWVKQA PGQGLEWIGY ISSYNGATNY
            NQKFKGRVTF TTDTSTSTAY MELRSLRSDD TAVYYCARDY DYDVGMDYWG QGTLVTVSSA
            STKGPSVFPL APCSRSTSES TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSNFGTQTY TCNVDHKPSN TKVDKTVERK CCVECPPCPA PPVAGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTFRV
            VSVLTVVHQD WLNGKEYKCK VSNKGLPAPI EKTISKTKGQ PREPQVYTLP PSREEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPMLDSDG SFFLYSKLTV DKSRWQQGNV
            FSCSVMHEAL HNHYTQKSLS LSPG
            (Light chain)
            DIVMTQSPDS LAVSLGERAT ISCRASESVD NYGISFMKWF QQKPGQPPKL LIYAASNQGS
            GVPDRFSGSG SGTDFTLTIS SLQAEDVAVY YCQQSKEVPW TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: H22-H96, H133-L218, H146-H202, H221-H'221, H222-H'222, H225-H'225, H228-H'228, H259-H319, H365-H423, H'22-H'96, H'133-L'218, H'146-H'202, H'259-H'319, H'365-H'423, L23-L92, L138-L198, L'23-L'92, L'138-L'198)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-delta-like 4 (DLL4) antibody
  TYPE      Monoclonal antibody
TARGET      DLL4 [HSA:54567] [KO:K06051]
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Notch signaling
                DLL4
                 D10353  Demcizumab (USAN/INN)
DBLINKS     CAS: 1243262-17-0
            PubChem: 172232446
///
